# Sumitomo Pharma America, Inc. – FDA Inspection, May 24, 2013

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/c12582b5-74d3-4a7d-a421-e9392e6a3fe4
Source feed: FDA_Inspections

> FDA inspection 843011 of Sumitomo Pharma America, Inc., May 24, 2013. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 843011
- Company Name: Sumitomo Pharma America, Inc.
- Inspection Date: 2013-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1242239 - 2024-08-02
- FDA Inspection 1161579 - 2021-11-05
- [FDA Inspection 915063 - 2015-01-23](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/d108866d-e164-4636-94bd-c5c66405a7b5)
- [FDA Inspection 759431 - 2011-12-09](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/7c1c1c35-c67a-4bf4-a6af-768c1a312d45)
- FDA Inspection 723394 - 2011-04-20

Company: https://www.keypedia.com/companies/sumitomo-pharma-america-inc/f5f01b1a-a43a-478e-a89c-f2d7c3003136

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c